Levetiracetam Seacross

Levetiracetam, the active ingredient in Levetiracetam Seacross, is an anticonvulsant presented as an intravenous solution for intravenous use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients who require rapid seizure control.

GNH USA supplies Levetiracetam Seacross as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levetiracetam is an anticonvulsant used to manage seizure disorders.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes. - Myoclonic seizures: decreases the occurrence of myoclonic jerks.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of swelling, rash, or breathing difficulty. - Stevens‑Johnson syndrome: serious skin blistering and detachment. - Suicidal thoughts or behavior: emergence of depressive mood or self‑harm ideation.

When using Levetiracetam, several safety considerations are recommended.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic dysfunction: use caution in patients with liver disease. - Pregnancy: classified as Category B; discuss potential risks with a healthcare professional. - Concomitant CNS depressants: observe for enhanced sedation. - Mood changes: watch for depression or suicidal ideation. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenytoin: can reduce levetiracetam exposure. - Phenobarbital: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Benzodiazepines: potential additive CNS depression. - Alcohol: may enhance sedative effects. - Fluoroquinolones: possible increase in neurotoxic symptoms.